Email This Article

Headlines & Perspectives
Vanda Ripe for Picking, or Dead on the Vine?
By Adam Feuerstein
06/08/09 - 04:35 PM EDT
A bull and a bear make their cases for whether a larger drug company will buy Vanda Pharmaceuticals.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,286.49 1,093.43 2,179.20 34.05
Oil *
75.57
DOWN
103.62
DOWN
9.82
DOWN
10.41
DOWN
0.43
10 Yr
3.40%
SPDR Gold
111.46
-1.00%
-0.89%
-0.48%
-1.25%
Data delayed 20 minutes

Brokerage Partners